Back to top
more

Labcorp (LH)

(Real Time Quote from BATS)

$230.64 USD

230.64
113,247

-0.06 (-0.03%)

Updated Aug 29, 2024 01:37 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth F Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 30% (175 out of 251)

Industry: Medical - Dental Supplies

Better trading starts here.

Zacks News

The Zacks Analyst Blog Highlights BioRad Laboratories, Henry Schein, Insulet, Abbott and LabCorp

BioRad Laboratories, Henry Schein, Insulet, Abbott and LabCorp are included in this Analyst Blog.

Urmimala Biswas headshot

3 MedTech Stocks Likely to Beat Estimates in Q1 Earnings

MedTech companies' results are likely to reflect base business recovery on a year-over-year basis. Let's see how BIO, HSIC and PODD are poised ahead of their earnings releases.

LabCorp (LH) Q1 Earnings Miss Estimates, Margins Decline

The decline in COVID-19 PCR and antibody testing sales, the severe foreign exchange headwind and inflationary pressure hurt LabCorp's (LH) business performance in Q1.

Compared to Estimates, LabCorp (LH) Q1 Earnings: A Look at Key Metrics

While the top- and bottom-line numbers for LabCorp (LH) give a sense of how the business performed in the quarter ended March 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

LabCorp (LH) Misses Q1 Earnings Estimates

LabCorp (LH) delivered earnings and revenue surprises of -4.26% and 0.87%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

LabCorp (LH) to Report Q1 Earnings: What's in the Cards?

Ongoing sales rebound in the base business for both Diagnostics and Drug Development segments is likely to have benefited LabCorp (LH) in Q1.

LabCorp (LH) Expands Colon Cancer Test Access With New Pact

LabCorp's (LH) at-home collection kit will offer patients an additional and easier option to get screened for colon cancer.

Is First Trust Health Care AlphaDEX ETF (FXH) a Strong ETF Right Now?

Smart Beta ETF report for FXH

Here's Why Investors Should Retain LabCorp (LH) Stock for Now

Investors are optimistic about LabCorp (LH) backed by strength in its Drug Development business.

LabCorp (LH) Focuses on High-Growth Areas Amid Currency Woe

In its efforts to expand further, LabCorp (LH) is focusing more on high-growth opportunity areas such as neurodegenerative, autoimmune and liver disease as well as cell and gene therapy.

The Zacks Analyst Blog Highlights TotalEnergies, America Movil, Palo Alto Networks, Manulife Financial and Laboratory Corporation of America

TotalEnergies, America Movil, Palo Alto Networks, Manulife Financial and Laboratory Corporation of America are included in this Analyst Blog.

Sheraz Mian headshot

Top Stock Reports for TotalEnergies, America Movil & Palo Alto Networks

Today's Research Daily features new research reports on 16 major stocks, including TotalEnergies SE (TTE), America Movil, S.A.B. de C.V. (AMX) and Palo Alto Networks, Inc. (PANW).

LabCorp (LH) Q4 Earnings Surpass Estimates, Margins Fall

The severe foreign exchange headwind, inflationary pressure and the ongoing Ukraine/Russia crisis impact LabCorp's (LH) business performance in Q4.

LabCorp (LH) Surpasses Q4 Earnings Estimates

LabCorp (LH) delivered earnings and revenue surprises of 1.97% and 2.05%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Exact Sciences (EXAS) to Post Q4 Earnings: What's in Store?

Continued increase in Cologuard volume is likely to have benefited Exact Sciences (EXAS) Q4 performance.

What's in the Cards for Medtronic (MDT) in Q3 Earnings?

Severe currency headwinds are expected to have affected Medtronic's (MDT) profitability in fiscal Q3.

LabCorp's (LH) New Launches, Planned Spinoff to Aid Growth

In terms of portfolio enhancement, LabCorp (LH) enters into a collaboration with Becton, Dickinson and Company to advance in life-changing treatments for cancer and other diseases.

Zacks Industry Outlook Highlights McKesson, AmerisourceBergen, LabCorp, Cardinal Health and Merit Medical

McKesson, AmerisourceBergen, LabCorp, Cardinal Health and Merit Medical have been highlighted in this Industry Outlook article.

STAAR Surgical (STAA) to Report Q4 Earnings: What's in Store?

Strong growth in EVO ICL units led by increased market adoption is likely to have driven STAAR Surgical's (STAA) Q4 revenues.

Indrajit Bandyopadhyay headshot

5 Dental Supplies Stocks to Buy Amid Recovering Prospects

Here, we discuss five stocks from the Dental Supplies industry that are likely to create wealth for investors - MCK, ABC, LH, CAH and MMSI.

AmerisourceBergen (ABC) Q1 Earnings Top, EPS View Raised

AmerisourceBergen's (ABC) fiscal first-quarter 2023 results benefit from segmental growth. Inflation and unfavorable currency rates hurt operating margin.

Boston Scientific (BSX) Q4 Earnings Miss, Operating Margin Up

Boston Scientific's (BSX) organic revenues at each of its core business segments and geographies increase in the fourth quarter of 2022.

Henry Schein (HSIC) to Report Q4 Earnings: What's in Store?

Henry Schein's (HSIC) dental business is likely to have gained in Q4 from the acquisition of Midway Dental.

Edwards Lifesciences (EW) Q4 Earnings Top, Margins Increase

Edwards Lifesciences (EW) continues to register strong momentum in TMTT, led by the continued adoption of the PASCAL platform in Europe.